Although the clinical relevance with the aforementioned cardiovascular danger factor alterations by tirzepatide are going to be assessed in the prepared cardiovascular consequence research SURPASS-CVOT ( "sort":"scientific-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examin